Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.

Robyn BruenSean CurleySarina KajaniDaniel CreanMarcella E O'ReillyMargaret B LucittCatherine G GodsonFiona C McGillicuddyOrina Belton

Published in: Cardiovascular diabetology (2017)

This data supports a therapeutic role for liraglutide as an atheroprotective agent via modulating macrophage cell fate towards MΦ2 pro-resolving macrophages.

Keyphrases

cell fate
adipose tissue
electronic health record
cardiovascular disease
signaling pathway
high fat diet induced
big data
anti inflammatory
machine learning
metabolic syndrome
artificial intelligence
deep learning
data analysis